We’ve partnered with tertiary analysis platforms, Genomize, Geneyx, & Golden Helix to enhance our hereditary cancer panel. Combining their analysis expertise with Oxford Nanopore sequencing to provide more precise oncology insights.

Learn more: https://t.co/g4bTrchdLb

#AACR26 https://t.co/1d1nASMTvu